ARCHIVES

Oral UFT Equivalent To FULV In Stage II and III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 7 | July 30, 2004

Download PDF Visit The Full Archive

Related Articles

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

June 28, 2013

In Brief: McDonnell Foundation Selects Five For Awards; James Benson Is Named Interim FDA Head

November 24, 1989

Arthur James, Ohio Founder Of Research Institute, Dead.

October 26, 2001

Funding Opportunities

September 6, 2002

Also in This 8-page Issue: In Overhaul of Ethics Rules, NIH Bans Employees From Consulting for and Owning Stock in Biomedical Companies.

February 4, 2005

Fellowships In Japan Available Through NIH

October 13, 1995